Nature Communications (Apr 2023)
An α-chloroaldehyde-based formal synthesis of eribulin
Abstract
Eribulin is an anticancer drug and the most structurally complex non-peptidic drug made by chemical synthesis. Here, the authors report a streamlined synthesis of eribulin that creates new opportunities for drug discovery and development.